2023 | | Bacterial Extracellular Vesicles: A Candidate Molecule for the Diagnosis and Treatment of Allergic Diseases | 박해심, 최영우 |
2024 | | Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia | 박해심 |
2023 | | Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice | 김승현, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2021 | | Biomarkers for severe Asthma: Lessons from longitudinal cohort studies | 박해심, 이영수 |
2023 | | Calcium ionophore-activated platelets induce eosinophil extracellular trap formation | 박해심, 최영우 |
2020 | | Cancer development in patients with COPD: a retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea | 박광주, 박범희, 박재범, 박주헌, 박지은, 박해심, 신승수, 황성철 |
2024 | | Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma | 박해심, 신유섭, 예영민 |
2020 | | Causes of food allergy according to age and severity: A recent 10-year retrospective study from a single tertiary hospital | 남동호, 박해심, 신유섭, 예영민, 이수영, 정경욱 |
2020 | | Ceramide/sphingosine-1-phosphate imbalance is associated with distinct inflammatory phenotypes of uncontrolled asthma | 김승현, 박해심 |
2021 | | Changes in type 2 biomarkers after anti-il5 treatment in patients with severe eosinophilic asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2021 | | Characteristics of Specialist-Diagnosed Asthma-COPD Overlap in Severe Asthma: Observations from the Korean Severe Asthma Registry (KoSAR) | 박해심, 이영수 |
2021 | | Clinical characteristics of NSAID-induced blended reaction | 박해심 |
2019 | | Clinical Manifestations and Risk Factors of Anaphylaxis in Pollen-Food Allergy Syndrome | 박해심 |
2021 | | Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2022 | | Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy | 박해심, 유민숙 |
2022 | | Contribution of dipeptidyl peptidase 10 to airway dysfunction in patients with NSAID-exacerbated respiratory disease | 박해심, 신유섭, 최영우 |
2024 | | Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma | 박해심, 신유섭, 유민숙, 장재혁, 최영우 |
2024 | | Contribution of non-neuronal cholinergic system to T2-low airway inflammation in severe asthma | 박해심, 장재혁 |
2023 | | Corrigendum to “Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma” [Clinical Immunology 255 (2023) 109755] | 박해심 |
2021 | | COVID-19 vaccine-associated anaphylaxis and allergic reactions: Consensus statements of the KAAACI urticaria/angioedema/anaphylaxis working group | 박해심, 예영민, 이수영 |
2020 | | COVID-19, asthma, and biological therapies: What we need to know | 박해심 |
2020 | | Current and Future Treatments of Rhinitis and Sinusitis | 박해심 |
2023 | | Current Issues in the Management of IgG Subclass Deficiencies in Adults With Chronic Respiratory Diseases | 박해심, 장재혁 |
2020 | | Detection of circulating IgG autoantibody to FcepsilonRIalpha in sera from chronic spontaneous urticaria patients | 박해심, 예영민 |
2022 | | Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
2024 | | Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2020 | | Diagnostic Models for Atopic Dermatitis Based on Serum Microbial Extracellular Vesicle Metagenomic Analysis: A Pilot Study | 박해심, 최영우 |
2019 | | Dimerized, Not Monomeric, Translationally Controlled Tumor Protein Induces Basophil Activation and Mast Cell Degranulation in Chronic Urticaria | 박해심, 예영민 |
2020 | | Distinct functions of eosinophils in severe asthma with type 2 phenotype: clinical implications | 박해심, 최영우 |
2021 | | Distribution and quality of life in patients with primary immunodeficiency diseases in a cohort of Korean adults | 박해심, 예영민 |
2022 | | Down-regulated surfactant protein B in obese asthmatics | 김승현, 박해심 |
2020 | | Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function | 박해심 |
2021 | | Effect of omalizumab as add-on therapy to quality of life questionnaire for korean asthmatics (Kaqlq) in korean patients with severe persistent allergic asthma | 박해심 |
2021 | | Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease | 박해심, 신유섭, 최영우 |
2022 | | Effectiveness of Maintenance and Reliever Therapy Using Inhaled Corticosteroid–Formoterol in Asthmatics | 박래웅, 박해심, 이영수, 장재혁 |
2020 | | Efficacy and Safety of a Pressurized Metered-Dose Inhaler in Older Asthmatics: Comparison to a Dry Powder Inhaler in a 12-Week Randomized Trial | 박주헌, 박해심, 신유섭, 예영민, 우성대, 이영수 |
2021 | | Efficacy and safety of mepolizumab in korean patients with severe eosinophilic asthma from the dream and mensa studies | 박해심 |
2020 | | Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma | 박해심 |
2020 | | Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma | 박해심 |
2020 | | Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma | 박해심 |
2019 | | Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications | 김승현, 박해심, 신승수, 신유섭, 예영민, 이소희, 정윤정 |
2023 | | Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines | 박해심, 신유섭, 예영민 |
2020 | | Efficacy, Safety, and Immunomodulatory Effect of the Intramuscular Administration of Autologous Total Immunoglobulin G for Atopic Dermatitis: A Randomized Clinical Trial | 남동호, 박해심, 신유섭, 예영민 |
2022 | | Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease | 박해심 |
2022 | | Emerging Hop Japanese Pollinosis in Asia | 박해심 |
2023 | | Endocrine-disrupting chemical exposure augments neutrophilic inflammation in severe asthma through the autophagy pathway | 박해심, 신유섭, 유민숙, 최영우 |
2023 | | Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma | 박해심 |
2021 | | Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity | 박해심, 정근옥, 최영우 |
2020 | | Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma | 김승현, 박해심, 신유섭, 최영우 |
2022 | | Epithelial Autoantigen-Specific IgG Antibody Enhances Eosinophil Extracellular Trap Formation in Severe Asthma | 박해심, 장재혁, 최영우 |
2021 | | Erratum: Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2021 | | Erratum: Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma | 박해심 |
2021 | | Establishment of reference intervals of serum immunoglobulins in healthy korean adults | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2020 | | Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients | 박해심, 신승수, 예영민 |
2022 | | Extracellular Traps: A Novel Therapeutic Target for Severe Asthma | 박해심, 최영우 |
2023 | | Functional Defects in B Lymphocytes in Asthmatic Patients With IgG Subclass Deficiency | 김승현, 박해심, 장재혁 |
2020 | | Health-Related Utility of EQ-5D in Korean Adults With Chronic Urticaria: Mapping From Urticaria Outcome Measures | 박해심, 신유섭, 예영민 |
2024 | | HLA-DRB1 is associated with cefaclor-induced immediate hypersensitivity | 박해심 |
2024 | | Immune Cell-Mediated Autoimmune Responses in Severe Asthma | 박해심, 장재혁 |
2022 | | Immunologic Basis of Type 2 Biologics for Severe Asthma | 박해심, 최영우 |